Cargando…
Investigation into Brazilian Palygorskite for Its Potential Use as Pharmaceutical Excipient: Perspectives and Applications
Palygorskite is an aluminum and magnesium silicate characterized by its fibrous morphology, providing it with great versatility in industrial applications, including pharmaceuticals. Although most of the reserves are in the United States, in recent years occurrences of commercially exploited deposit...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381531/ https://www.ncbi.nlm.nih.gov/pubmed/37512238 http://dx.doi.org/10.3390/ma16144962 |
_version_ | 1785080467167379456 |
---|---|
author | Meirelles, Lyghia Maria Araújo Barbosa, Raquel de Melo Sanchez-Espejo, Rita García-Villén, Fátima Perioli, Luana Viseras, César Moura, Tulio Flavio Accioly de Lima e Raffin, Fernanda Nervo |
author_facet | Meirelles, Lyghia Maria Araújo Barbosa, Raquel de Melo Sanchez-Espejo, Rita García-Villén, Fátima Perioli, Luana Viseras, César Moura, Tulio Flavio Accioly de Lima e Raffin, Fernanda Nervo |
author_sort | Meirelles, Lyghia Maria Araújo |
collection | PubMed |
description | Palygorskite is an aluminum and magnesium silicate characterized by its fibrous morphology, providing it with great versatility in industrial applications, including pharmaceuticals. Although most of the reserves are in the United States, in recent years occurrences of commercially exploited deposits in Brazil have been recorded, mainly in the country’s northeast region. This has motivated this study, which analyzes raw Brazilian palygorskite compared to a commercial sample (Pharmasorb(®) colloidal) to demonstrate its pharmaceutical potential. The chemical and mineral composition of the samples were evaluated for surface properties, granulometry, morphology, crystallography, thermal analysis, and spectroscopy. Raw palygorskite presented 67% purity, against 74% for Pharmasorb(®) colloidal. The percentage purity relates to the presence of contaminants, mainly carbonates and quartz (harmless under conventional conditions of pharmaceutical use). Furthermore, it was possible to confirm the chemical composition of these phyllosilicates, formed primarily of silicon, aluminum, and magnesium oxides. The crystallographic and spectroscopic profiles were consistent in both samples, showing characteristic peaks for palygorskite (2θ = 8.3°) and bands attributed to fibrous phyllosilicates below 1200 cm(−1), respectively. The thermal analysis allowed the identification of the main events of palygorskite, with slight differences between the evaluated samples: loss of water adsorbed onto the surface (~85 °C), removal of water contained in the channels (~200 °C), coordinated water loss (~475 °C), and, finally, the dehydroxylation (>620 °C). The physicochemical characteristics of raw palygorskite align with pharmacopeial specifications, exhibiting a high specific surface area (122 m(2)/g), moderately negative charge (−13.1 mV), and compliance with the required limits for heavy metals and arsenic. These favorable technical attributes indicate promising prospects for its use as a pharmaceutical ingredient in the production of medicines and cosmetics. |
format | Online Article Text |
id | pubmed-10381531 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103815312023-07-29 Investigation into Brazilian Palygorskite for Its Potential Use as Pharmaceutical Excipient: Perspectives and Applications Meirelles, Lyghia Maria Araújo Barbosa, Raquel de Melo Sanchez-Espejo, Rita García-Villén, Fátima Perioli, Luana Viseras, César Moura, Tulio Flavio Accioly de Lima e Raffin, Fernanda Nervo Materials (Basel) Article Palygorskite is an aluminum and magnesium silicate characterized by its fibrous morphology, providing it with great versatility in industrial applications, including pharmaceuticals. Although most of the reserves are in the United States, in recent years occurrences of commercially exploited deposits in Brazil have been recorded, mainly in the country’s northeast region. This has motivated this study, which analyzes raw Brazilian palygorskite compared to a commercial sample (Pharmasorb(®) colloidal) to demonstrate its pharmaceutical potential. The chemical and mineral composition of the samples were evaluated for surface properties, granulometry, morphology, crystallography, thermal analysis, and spectroscopy. Raw palygorskite presented 67% purity, against 74% for Pharmasorb(®) colloidal. The percentage purity relates to the presence of contaminants, mainly carbonates and quartz (harmless under conventional conditions of pharmaceutical use). Furthermore, it was possible to confirm the chemical composition of these phyllosilicates, formed primarily of silicon, aluminum, and magnesium oxides. The crystallographic and spectroscopic profiles were consistent in both samples, showing characteristic peaks for palygorskite (2θ = 8.3°) and bands attributed to fibrous phyllosilicates below 1200 cm(−1), respectively. The thermal analysis allowed the identification of the main events of palygorskite, with slight differences between the evaluated samples: loss of water adsorbed onto the surface (~85 °C), removal of water contained in the channels (~200 °C), coordinated water loss (~475 °C), and, finally, the dehydroxylation (>620 °C). The physicochemical characteristics of raw palygorskite align with pharmacopeial specifications, exhibiting a high specific surface area (122 m(2)/g), moderately negative charge (−13.1 mV), and compliance with the required limits for heavy metals and arsenic. These favorable technical attributes indicate promising prospects for its use as a pharmaceutical ingredient in the production of medicines and cosmetics. MDPI 2023-07-12 /pmc/articles/PMC10381531/ /pubmed/37512238 http://dx.doi.org/10.3390/ma16144962 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Meirelles, Lyghia Maria Araújo Barbosa, Raquel de Melo Sanchez-Espejo, Rita García-Villén, Fátima Perioli, Luana Viseras, César Moura, Tulio Flavio Accioly de Lima e Raffin, Fernanda Nervo Investigation into Brazilian Palygorskite for Its Potential Use as Pharmaceutical Excipient: Perspectives and Applications |
title | Investigation into Brazilian Palygorskite for Its Potential Use as Pharmaceutical Excipient: Perspectives and Applications |
title_full | Investigation into Brazilian Palygorskite for Its Potential Use as Pharmaceutical Excipient: Perspectives and Applications |
title_fullStr | Investigation into Brazilian Palygorskite for Its Potential Use as Pharmaceutical Excipient: Perspectives and Applications |
title_full_unstemmed | Investigation into Brazilian Palygorskite for Its Potential Use as Pharmaceutical Excipient: Perspectives and Applications |
title_short | Investigation into Brazilian Palygorskite for Its Potential Use as Pharmaceutical Excipient: Perspectives and Applications |
title_sort | investigation into brazilian palygorskite for its potential use as pharmaceutical excipient: perspectives and applications |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381531/ https://www.ncbi.nlm.nih.gov/pubmed/37512238 http://dx.doi.org/10.3390/ma16144962 |
work_keys_str_mv | AT meirelleslyghiamariaaraujo investigationintobrazilianpalygorskiteforitspotentialuseaspharmaceuticalexcipientperspectivesandapplications AT barbosaraqueldemelo investigationintobrazilianpalygorskiteforitspotentialuseaspharmaceuticalexcipientperspectivesandapplications AT sanchezespejorita investigationintobrazilianpalygorskiteforitspotentialuseaspharmaceuticalexcipientperspectivesandapplications AT garciavillenfatima investigationintobrazilianpalygorskiteforitspotentialuseaspharmaceuticalexcipientperspectivesandapplications AT perioliluana investigationintobrazilianpalygorskiteforitspotentialuseaspharmaceuticalexcipientperspectivesandapplications AT viserascesar investigationintobrazilianpalygorskiteforitspotentialuseaspharmaceuticalexcipientperspectivesandapplications AT mouratulioflavioacciolydelimae investigationintobrazilianpalygorskiteforitspotentialuseaspharmaceuticalexcipientperspectivesandapplications AT raffinfernandanervo investigationintobrazilianpalygorskiteforitspotentialuseaspharmaceuticalexcipientperspectivesandapplications |